Small-cap healthcare and emerging growth stocks continue to generate investor interest as multiple companies announced ...

FDA feedback provides detailed manufacturing and formulation requirements for continued late-stage development of NEO212CALABASAS, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings ...

NTHI to provide ongoing news coverage of expected upcoming catalysts and events as well as market outreach services. This should not be construed as financial or investment advice. Trading involves ...

RT-114 achieved systemic exposure greater than 150% relative to a matched 12mg subcutaneous dose of PG-102No adverse events attributed to ...

BioNxt Shares Poised for a Comeback? BioNxt Solutions focuses on developing innovative dosage forms for already-approved ...

New Preclinical Data Demonstrate Favorable Oral Bioavailability, Robust Brain Penetration and Liver Exposure with ...

Research indicates that certain statins, particularly atorvastatin and simvastatin, may elevate the risk of erectile ...

In a study published in Signal Transduction and Targeted Therapy, the researchers used MIR2911, a plant microRNA enriched in honeysuckle, as a proof-of-concept example.

remove-circle Internet Archive's in-browser bookreader "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see ...

In the pharmaceutical industry, Bioavailability (BA) and Bioequivalence (BE) studies play a crucial role in ensuring drug safety, efficacy, and therapeutic consistency. These studies are essential for ...

Researchers from the University of Chemistry and Technology Prague and the Institute for Clinical and Experimental Medicine have found that cannabidiolic acid (CBDA) has far stronger bioavailability ...